Both in Pharmaceuticals
Bicara Therapeutics vs Climb Bio
Over the past year BCAX returned −45.1% and CLYM returned +369.0%; their daily moves had a correlation of 0.19.
BCAX −45.1% CLYM +369.0%Growth of $1, one year, split-adjusted
| Metric | BCAX | CLYM |
|---|---|---|
| Price | $8.96 | $9.75 |
| Market cap | $592.9M | $560.0M |
| Today | +12.99% | +0.10% |
| 1 month | −48.2% | −11.8% |
| 6 months | −61.3% | −14.8% |
| Year to date | −46.8% | +143.8% |
| 1 year | −44.9% | +375.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $497.3M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | 134.8% | 80.7% |
| Short % of float | 23.9% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).